Mortaz et al., 2013 - Google Patents
Probiotics in the management of lung diseasesMortaz et al., 2013
View PDF- Document ID
- 9017316788605309009
- Author
- Mortaz E
- Adcock I
- Folkerts G
- Barnes P
- Paul Vos A
- Garssen J
- Publication year
- Publication venue
- Mediators of inflammation
External Links
Snippet
The physiology and pathology of the respiratory and gastrointestinal tracts are closely related. This similarity between the two organs may underlie why dysfunction in one organ may induce illness in the other. For example, smoking is a major risk factor for COPD and …
- 230000000529 probiotic 0 title abstract description 73
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mortaz et al. | Probiotics in the management of lung diseases | |
| Toh et al. | Probiotic therapy as a novel approach for allergic disease | |
| Abbasi et al. | The biological activities of postbiotics in gastrointestinal disorders | |
| Lu et al. | Probiotics in cancer | |
| Reid et al. | New scientific paradigms for probiotics and prebiotics | |
| Skalski et al. | Expansion of commensal fungus Wallemia mellicola in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice | |
| Doron et al. | Probiotics: their role in the treatment and prevention of disease | |
| Roessler et al. | The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention | |
| Marasco et al. | Probiotics, prebiotics and other dietary supplements for gut microbiota modulation in celiac disease patients | |
| Scaldaferri et al. | Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility | |
| Lefevre et al. | Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study | |
| Fiocchi et al. | Clinical use of probiotics in pediatric allergy (CUPPA): a world allergy organization position paper | |
| Ceapa et al. | Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health | |
| Howarth et al. | Role of endogenous microbiota, probiotics and their biological products in human health | |
| Rupa et al. | Recent advances in the role of probiotics in human inflammation and gut health | |
| Liu et al. | Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation | |
| Kim et al. | Clinical efficacy and mechanism of probiotics in allergic diseases | |
| Ghaffari et al. | Akkermansia muciniphila: From its critical role in human health to strategies for promoting its abundance in human gut microbiome | |
| Hord | Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics | |
| Nonaka et al. | Antiallergic effects of Lactobacillus pentosus strain S-PT84 mediated by modulation of Th1/Th2 immunobalance and induction of IL-10 production | |
| Taylor et al. | Effects of probiotic supplementation for the first 6 months of life on allergen‐and vaccine‐specific immune responses | |
| Zhang et al. | Next‐Generation Probiotics: Microflora Intervention to Human Diseases | |
| You et al. | Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486 | |
| Blandino et al. | Probiotics: overview of microbiological and immunological characteristics | |
| Atabati et al. | Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies |